Leading provider of high-quality, system-critical elastomer components
With recognized core competencies in solution design, material know-how and product industrialization, we are a strategic engineering partner for innovative systems in Healthcare, Transportation & Electronics, General Industry and Food & Beverage. Read more about us.
SoftPulse® Dry Electrodes for Biosignal Monitoring
Boosting your wearable application to the next level with SoftPulse®
Soft dry electrodes can be used for easy, comfortable, and long-term monitoring of bio-signals like EEG, ECG, EMG and EOG for consumer as well as medical applications.
Prefilled Syringe Components
NeoFlex™ Plungers: Superior Drug Delivery Solutions
Datwyler’s NeoFlex™ Plungers: The Reliable Choice for Prefilled Syringes and Cartridges. Our premium plungers offer superior performance and compliance for self-administration devices, meeting the highest industry standards.
Electro Active Polymers (EAP)
Advanced manufacturing of a novel actuation technology
Actuators are mechanical components that allow the transformation of electrical energy into mechanical energy and enable a multipurpose and efficient operation.
Latest news
Datwyler generated net revenue of CHF 582.7 million in the first half of 2026, up from CHF 563.0 million in the prior-year period, representing an organic growth of 4.6%. Division Healthcare continued its positive momentum, while Division Industrial remained affected by subdued end-markets and additional headwinds stemming from the conflict in the Middle East.
Datwyler welcomed Delaware Governor Matt Meyer today at its Middletown manufacturing facility, reinforcing the company’s commitment to healthcare manufacturing, innovation and workforce development in Delaware.
Datwyler announces changes to its Executive Board in order to strengthen its organization and set a clear course for the future.
The 68th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 17 March 2026. Share-holders approved all Board proposals by a large majority.
Datwyler has successfully completed the acquisition of a majority stake in Capsul’in as announced in December 2025.
Billions of syringes worldwide contain Datwyler components. We are global number two for Sealing Solutions for Parenteral Medicines & Medical Devices.
Sustainability
Working towards reduction targets
Continuous improving processes
We are dedicated to continuous improvement in all we do. Our quality management system is supported by digitalisation thus enabling analysis, exchange of knowledge, and standardisation. We use a risk-based approach and our expertise to meet the changing needs of our customers and other stakeholders and to shape future oriented processes.
Sustainability
Improving water availability
Washing system at Datwyler plant in Alken, Belgium
Employee Spotlight
Top solutions for global customers
Reto Burkart
Site Director Schattdorf, Switzerland
Upcoming Events
Basel, Switzerland
